Evidence map›Paper›PMID 39732825›Full record

ArticleScientific reports2024

Tunable and ultra-narrowband multifunctional terahertz devices using anisotropic graphene based hyperbolic metamaterials.

Shahab Tavana, Shahram Bahadori-Haghighi, Winnie N Ye

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Shahab TavanaDepartment of Electronics, Carleton University, Ottawa, ON, K1S 5B6, Canada.
Shahram Bahadori-HaghighiDepartment of Communications and Electronics, School of Electrical and Computer Engineering, Shiraz University, Shiraz, Iran. sbahadori@shirazu.ac.ir.
Winnie N YeDepartment of Electronics, Carleton University, Ottawa, ON, K1S 5B6, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this paper, we propose a novel structure of anisotropic graphene-based hyperbolic metamaterial (AGHMM) sandwiched as a defect between two one-dimensional photonic crystals (PCs) in the terahertz (THz) region. The proposed structure is numerically simulated and analyzed using the transfer matrix method, effective medium theory and three-dimensional finite-difference time-domain. The defect layer of AGHMM consists of graphene sheets separated by subwavelength dielectric spacers. According to the presented results, a sharp defect mode originated from the optical Tamm state (OTS) takes place at the interfaces between PCs and AGHMM. The platform is then applied as various THz devices with outstanding characteristics compared with their previous counterparts. The performance of all the proposed devices can be tuned by changing the incident angle and graphene chemical potential. Our designed electro-optical modulator exhibits a high extinction ratio of 24.75 dB. The required switching voltage and insertion loss are as low as 9.94 V and 0.05 dB, respectively. Owing to the anisotropy of graphene, a tunable polarizer over wide incident angles is attained. The highest polarization extinction ratios (PERs) for TE- and TM-pass polarizers are 42.4 dB and 76.8 dB, respectively, which are the highest PER ever reported. By introducing more AGHMM defects, multiband tunable filters with quality factors of as high as 75314 are realized. Finally, a narrowband perfect absorber is proposed so that a high absorption of 99.8% with an ultra-narrow FWHM of 0.00055 THz is achieved. Hence, the proposed structure is a promising platform that could have many potential THz applications.

Identifiers

PMID39732825
PMCPMC11682465

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.